Hydroxyzine Pamoate Capsule
Product Images NDC 51655-252

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51655-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
Chemical structure diagram showing the molecular structure of Hydroxyzine Pamoate, the active ingredient. The image depicts the two chemical components forming the pamoate salt, including a chloro-substituted phenyl ring, piperazine ring, and a complex polycyclic acid moiety.*
FDA Label Image

Label (51655 252 52 Rev A 04 23 Nhc)

Label (51655 252 52   Rev A 04 23 Nhc)
Label for Hydroxyzine Pamoate Capsules, USP 50 mg, containing 30 capsules per container. The label indicates it is a prescription drug, stored at controlled room temperature, and packaged by Northwind Health Company, LLC. Includes directions to see package insert for dosage and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.